BHC

Bausch Health

• Dow Jones·6d ago

  *News On Durect Corp. (DRRX) Now Under BHC.T

• Dow Jones·08/15 19:06

  Carl Icahn's Son, Icahn Capital Portfolio Manager Exit Bausch Health Board

• Dow Jones·08/15 18:32

  *Bausch Health: Icahn Group Net Long Position Fell Below Specified Threshold >BHC

• Dow Jones·08/15 18:32

  *Bausch Health: Director Appointment and Nomination Agreement With Icahn Group Terminated Pursuant to Terms >BHC

• Dow Jones·08/15 18:31

  *Bausch Health: Brett M. Icahn, Steven D. Miller Resign From Board

• Dow Jones·07/30 20:15

  *Bausch Health Sees FY Rev $10B-$10.25B >BHC

• Dow Jones·07/30 20:14

  *Bausch Health 2Q Rev $2.53B >BHC

• Dow Jones·07/29 14:15

  Durect Shares Soar With Takeover Offer From Bausch Health

• Dow Jones·07/29 11:36

  Bausch to Buy Biopharmaceutical Company Durect for $63 Million Upfront

• Dow Jones·07/29 11:12

  *Bausch: Registrational Phase 3 Pgrm to Evaluate Safety and Efficacy of Larsucosterol to Treat Severe AH Being Planned

• Dow Jones·07/29 11:09

  *Durect: Deal Has Potential for Two Additional Milestone Payments of Up to $350M >DRRX

• Dow Jones·07/29 11:08

  *Durect: Bausch to Pay $1.75 Per Shr in All-Cash Transaction >DRRX

• Dow Jones·07/29 11:08

  *Durect: Deal is for Consideration of About $63M >DRRX

• Dow Jones·07/29 11:06

  *Durect: Acquisition Includes Therapeutic Molecule, Larsucosterol >DRRX

• Dow Jones·07/29 11:05

  *Bausch Health to Acquire DURECT for $63M, or $1.75/Share >BHC DRRX